Your browser doesn't support javascript.
loading
Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumab.
Bar-Or, Amit; Aburashed, Rany; Chinea, Angel R; Hendin, Barry A; Lucassen, Elisabeth; Meng, Xiangyi; Stankiewicz, James; Tullman, Mark J; Cross, Anne H.
Affiliation
  • Bar-Or A; Department of Neurology, and Center for Neuroinflammation and Experimental Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States. Electronic address: amitbar@pennmedicine.upenn.edu.
  • Aburashed R; Insight Chicago Hospital and Medical Center, Chicago, IL, United States.
  • Chinea AR; San Juan MS Center, Guaynabo, Puerto Rico.
  • Hendin BA; Center for Neurology and Spine, Phoenix, AZ, United States.
  • Lucassen E; Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States.
  • Meng X; Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States.
  • Stankiewicz J; Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States.
  • Tullman MJ; Mercy Clinic, St. Louis, MO, United States.
  • Cross AH; Washington University School of Medicine, St. Louis, MO, United States.
Mult Scler Relat Disord ; 79: 104967, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37769429
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Type of study: Clinical_trials / Qualitative_research Limits: Adult / Humans Language: En Journal: Mult Scler Relat Disord Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Type of study: Clinical_trials / Qualitative_research Limits: Adult / Humans Language: En Journal: Mult Scler Relat Disord Year: 2023 Type: Article